14 Results for "

Farnesyl pyrophosphate synthase

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Farnesyl pyrophosphate synthase" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-16011
CAS No.: 152831-36-2
Synonyms: 3-PEHPC
Target:  

Farnesyl Transferase

Research Areas:  

Others

NE 10790, a poor farnesyl pyrophosphate synthase inhibitor, is a phosphonocarboxylate analogue of the potent bisphosphonate risedronate and is a weak antiresorptive agent.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515
CAS No.: 138926-19-9
Synonyms: BM-210955; RPR-102289A
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium Monohydrate (BM-210955; RPR-102289A) is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium Monohydrate can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium Monohydrate inhibits tumor cell proliferation (such as ER + breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium Monohydrate is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515B
CAS No.: 138844-81-2
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium inhibits tumor cell proliferation (such as ER+ breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W585869
CAS No.: 92692-39-2
Amorphadiene is the precursor to the antimalarial agent artemisinin, which is produced through the amorphadiene synthase (ADS)-catalyzed cyclization of farnesyl pyrophosphate (FPP) yeast .
loading...
    loading...
Cat. No.: HY-P75196
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FDPS; FPP synthase; Farnesyl Diphosphate synthase; FPS; (2E,6E)-Farnesyl Diphosphate synthase; Alternative Protein FDPS; Farnesyl pyrophosphate synthase; FPP Synthetase; Farnesyl pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransfe
Species:  
Mouse
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P75197
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: FDPS; FPP synthase; Farnesyl Diphosphate synthase; FPS; (2E,6E)-Farnesyl Diphosphate synthase; Alternative Protein FDPS; Farnesyl pyrophosphate synthase; FPP Synthetase; Farnesyl pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransfe
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-176855
Target:  

Bacterial

Research Areas:  

Metabolic Disease Cancer

RAM1147 is a farnesyl pyrophosphate synthase (FPPS) inhibitor. RAM1147 disrupts protein isoprenylation, inhibiting tumor cell proliferation. RAM1147 is promising for research of cancers (e.g., myeloma, breast cancer) and bone metabolism disorders (e.g., osteoporosis) .
loading...
    loading...
Cat. No.: HY-117012
CAS No.: 105462-23-5
Target:  

Endogenous Metabolite

Research Areas:  

Others

NE58018 is a compound with bone resorption inhibitory activity. NE58018 exerts its effect by affecting the action of Farnesyl pyrophosphate synthase (FPPS). The structural features of NE58018 combined with aminophosphonates significantly enhance its inhibitory activity. NE58018 affects the roles of Thr201 and Tyr204 residues in substrate binding and catalysis. The interaction of NE58018 enhances the inhibitory effect on the target enzyme .
loading...
    loading...
Cat. No.: HY-B0515R
CAS No.: 138926-19-9
Synonyms: BM-210955 (Standard); RPR-102289A (Standard)
Research Areas:  

Cancer

Ibandronate Sodium Monohydrate (BM-210955; RPR-102289A) (Standard) is the analytical standard of Ibandronate Sodium Monohydrate (HY-B0515). This product is intended for research and analytical applications. Ibandronate Sodium Monohydrate (BM-210955; RPR-102289A) is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium Monohydrate can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium Monohydrate inhibits tumor cell proliferation (such as ER + breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium Monohydrate is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
Cat. No.: HY-P70224
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GGPS1; GGPPS1; Geranylgeranyl Diphosphate synthase 1; Geranylgeranyl Diphosphate synthase; Geranylgeranyl pyrophosphate synthase; GGPP synthase; (2E,6E)-Farnesyl Diphosphate synthase; GGPPSase; Dimethylallyltranstransferase; MUDHLOV; Farnesyl Diphosphate
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P702577
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GGPS1; GGPPS1; Geranylgeranyl Diphosphate synthase 1; Geranylgeranyl Diphosphate synthase; Geranylgeranyl pyrophosphate synthase; GGPP synthase; (2E,6E)-Farnesyl Diphosphate synthase; GGPPSase; Dimethylallyltranstransferase; MUDHLOV; Farnesyl Diphosphate
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-148969
CAS No.: 1250273-31-4
Target:  

Others

Research Areas:  

Cancer

FPPS-IN-1 is a potent non-bisphosphonate Farnesyl pyrophosphate synthase (FPPS) inhibitor with an IC50 0.2 μM. FPPS-IN-1 can be used for the research of cancers .
loading...
    loading...
Cat. No.: HY-W100829
CAS No.: 51527-19-6
Target:  

Drug Intermediate

Research Areas:  

Others

FPPS ligand 3 (compound 2) is a farnesyl pyrophosphate synthase (FPPS) ligand. FPPS ligand 3 binds to the hydrophobic base region of the FPPS pocket. FPPS ligand 3 can be used to design and synthesize FPPS inhibitors .
loading...
    loading...
Cat. No.: HY-182516
CAS No.: 32545-60-1
Target:  

Farnesyl Transferase

Research Areas:  

Infection Others

Aminobutane bisphosphonate is a Trypanosoma cruzi farnesyl pyrophosphate synthase (FPPS) inhibitor with an IC50 of 30.77 μM against Trypanosoma cruzi. Aminobutane bisphosphonate inhibits proliferation of intracellular amastigote Trypanosoma cruzi and lacks activity against non-infective epimastigote forms. Aminobutane bisphosphonate reduces osteoclastic bone resorption, osteoid surface extent, and osteoclast number per mm of bone surface. Aminobutane bisphosphonate can be used for the research of american trypanosomiasis (chagas' disease) and immobilization-related bone loss .
loading...
    loading...
  • 1